Abstract
Argyrophilic nucleolar organizer region (Ag-NOR) analysis, proliferating cell nuclear antigen (PC-NA/PC10) and MIB-1 immunohistochemistry, nuclear morphometry and DNA flow cytometry have been performed on formalin-fixed, paraffin-embedded biopsies from 50 patients with transitional cell carcinoma of the urinary bladder. The mean AgNOR count was 6.01 for the 17 grade 1 (G1), 7.59 for the 21 G2 and 13.33 for the 12 G3 carcinomas (p<0.001). The mean PCNA score was 15.03% for G1, 24.04% for G2 and 40.01% for G3 cases (p<0.001). The mean MIB-1 score was 11.31% for G1, 17.09% for G2 and 34.47% for G3 carcinomas (p<0.001). The mean nuclear area was 35.53 μm2 for G1, 38.65 μm2 for G2 and 83.62 μm2 for G3 cases (p<0.001). Aneuploidy rates were significantly higher (91.7%) in G3 than in G2 (42.9%, p<0.01) or G1 cases (47.1%, p<0.05) but not different for G1 versus G2 cases (p=0.94). While many overlaps of values were seen between G1 and G2 tumours, no overlaps were found between G3 and G1/G2 tumours. Significant differences of values were also found between pTa and invasive tumours (p<0.0001 for AgNOR count and PCNA score; p<0.001 for MIB-1 score and mean nuclear area; p<0.01 for DNA ploidy); however many overlaps were seen. Our findings indicate that the quantitative parameters obtained with different methods are associated with histological grade of bladder urotheliomas and may improve the grading reproducibility. In addition, the absence of overlaps between G3 and G2/G1 carcinomas supports the tendency to classify bladder urotheliomas in only two categories of malignancy.
Similar content being viewed by others
References
Badalament RA, O'Toole RV, Kenworthy P, Young DC, Keyhani Rofagha S, Simon J, Perez JF, Drago JR (1990) Prognostic factors in patients with primary transitional cell carcinoma of the upper urinary tract. J Urol 144:859–863
Bergkvist A, Ljungqvist A, Moberger G (1965) Classification of bladder tumours based on the cellular pattern: preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of 8 years. Acta Chir Scand 130:371–378
Bjelkenkrantz K, Herder A, Gröntoft O, St»l O (1982) Cytophotometric characterization of the WHO grades of transitional cell neoplasms. Pathol Res Pract 174:68–77
Blomjous CEM, Schipper NW, Baak JPA, Van Galen EM, Meijer CJLM (1988) Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. J Clin Pathol 41:21–25
Blomjous ECM, Schipper NW, Baak JPA, Vos W, de Voogt HJ, Meijer CJLM (1989a) The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Pathol 91:243–248
Blomjous ECM, Schipper NW, Vos W, Baak JPA, de Voogt HJ, Meijer CJLM (1989b) Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. Virchows Arch [A] 415:721–728
Blomjous ECM, Smeulders AW, Baak JPA, Vos W, van Galen CM, Meijer CJLM (1989c) A comparative study in morphometric grading of transitional cell carcinoma of the urinary bladder. Anal Quant Cytol Histol 11:426–432
Blomjous CEM, Vos W, Schipper NW, Uyterlinde AM, Baak JPA, De Voogt HJ, Meijer CJLM (1990) The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma. Hum Pathol 21:409–413
Busch C, Engberg A, Norlen BJ, Stenkvist B (1975) Malignancy grading of epithelial bladder tumours. Scand J Urol Nephrol 1:140–143
Bush C, Price P, Norton J, Parkins CS, Bailey MJ, Boyd J, Jones CR, A'Hern RP, Horwich A (1991) Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer 64:357–360
Cairns P, Suarez V, Newman J, Crocker J (1989) Nucleolar organizer regions in transitional cell tumors of the bladder. Arch Pathol Lab Med 113:1250–1252
Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Gall J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363
Coon JS, Landay AL, Weinstein RS (1986) Flow cytometric analysis of paraffin-embedded tumors: Implications for diagnostic pathology. Hum Pathol 11:435–437
Derenzini M, Pession A, Trerè D (1990) Quantity of nucleolar silver-stained proteins is related to proliferative activity in cancer cells. Lab Invest 63:137–140
Gall JG, Pardue ML (1969) Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci USA 63:378–383
Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20
Hall PA, Levison DA (1990) Assessment of cell proliferation in histological material. J Clin Pathol 43:184–192
Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294
Hansen AB, Bjerregaard B, Ovensen H, Horn T (1992) AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern. Histopathology 20:257–262
Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333–1335
Heiden T, Strang P, Stendahl U, Tribukait B (1990) The reproducibility of flow cytometric analyses in human tumors. Methodological aspects. Anticancer Res 10:49–54
Helander K, Hofer PA, Holmberg G (1984) Karyometric investigations on urinary bladder carcinoma, correlated to histopathological grading. Virchows Arch [A] 403:117–125
Hermanek P, Sobin LH (1987) TNM Classification of Malignant Tumours. 4th ed. Springer, Berlin Heidelberg New York
Hufnagl P, Beil M, Wenzelides K, Martin H (1991) Measurement of the number, size and location of AgNORs in histologic sections of astrocytomas and bladder carcinoma. Zentralbl Pathol 137:493–497
Joensuu H, Klemi PJ (1988) Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma. Am J Clin Pathol 89:35–40
Jordan A, Weingarten J, Murphy WM (1987) Transitional cell neoplasm of the urinary bladder. Cancer 60:2766–2774
Key G, Becker MHG, Duchrow M, Schluter C, Gerdes J (1992) New Ki-67 equivalent murine monoclonal antibodies (MIB-1–3) prepared against recombinant parts of the Ki-67 antigen. Anal Cell Pathol 4:181
Koss LG (1975) Tumors of the urinary bladder. In: Atlas of tumor pathology, series 2, fascicle 11, Washington DC, Armed Forces Institute of Pathology, pp. 16–17
Limas C, Bigler A, Bair R, Bernhart P, Reddy P (1993) Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organizer regions. J Clin Pathol 46:159–165
Lipponen PK, Eskelinen MJ (1992) Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer 66:171–176
Lipponen PK, Eskelinen MJ, Nordling S (1991a) Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy. Eur J Cancer 27:877–881
Lipponen PK, Eskelinen MJ, Nordling S (1991b) Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer. Br J Cancer 64:1139–1144
Mathews MB, Bernstein RM, Franza BR, Garrels JI (1984) Identity of the proliferating cell nuclear antigen and cyclin. Nature 303:374–376
Mellon K, Neal DE, Robinson MC, Marsh C, Wright C (1990) Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67. Br J Urol 66:281–285
Mostofi FK, Sobin LH, Torloni H (1973) Histological typing of urinary bladder tumours. International classification of tumours. N. 10. World Health Organization, Geneva
Mulder AH, Van Hootegem JC, Sylvester R, Ten Kate FJ, Kurth KH, Ooms EC, Van der Kwast TH (1992) Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol 166:37–43
Norming U, Nyman CR, Tribukait B (1989) Comparative flow cytometric deoxyribonucleic acid studies on exophitic tumor and random mucosal biopsies in untreated carcinoma of the bladder. J Urol 142:1442–1447
Ooms ECM, Veldhuizen RW (1989) Argyrophilic proteins of nucleolar organizer region in bladder tumours. Virchows Arch [A] 414:365–369
Ooms ECM, Anderson WAD, Alons CL, Boon ME, Veldhuizen RW (1983a) Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 14:140–143
Ooms ECM, Kurver PHJ, Veldhuizen RW, Alons CL, Boon ME (1983b) Morphometric grading of bladder tumors in comparison with histologic grading by pathologists. Hum Pathol 14:144–150
Pich A, Pisani P, Krengli M, Cappello N, Navone R (1991) Argyrophilic nucleolar organizer region counts and prognosis in pharyngeal carcinoma. Br J Cancer 64:327–332
Pich A, Comino A, Chiusa L, Fruttero A, Navone R (1992) Argyrophilic nucleolar organizer regions (AgNORs) counts, proliferating cell nuclear antigen (PCNA) scores and DNA flow cytometry of bladder urotheliomas in routinely treated biopsies. XIX International Congress of the International Academy of Pathology, Madrid 18–23 October 1992. Patologia 25:123–124
Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ (1986) Improvement in the staining and in the visualisation of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18:5–14
Rüschoff J, Plate K, Bittinger A, Thomas C (1989) Nuclear organizer regions (NORs). Basic concepts and practical application in tumor pathology. Pathol Res Pract 185:878–887
Rüschoff J, Zimmermann R, Ulshöfer B, Thomas C (1992) Silverstained nucleolar organizer proteins in urothelial bladder lesions. A morphometric study. Pathol Res Pract 188:593–598
Skopelitou A, Korkolopoulou P, Papanikolaou A, Christodoulou P, Thomas-Tsagli E, Pavlakis K (1992) Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of urinary bladder. Correlation with other conventional prognostic pathologic parameters. Eur Urol 22:235–240
Waldman FM, Carroll PR, Cohen MB, Kerschmann R, Chew K, Mayall BH (1993) 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Mod Pathol 6:20–24
Wheeless LL, Badalament RA, de Vere White RW, Fradet Y, Tribukait B (1993) Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14:478–481
Yu CC-W, Hall PA, Fletcher CDM, Camplejohn R, Waseem NH, Lane DP, Levison DA (1991) Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PC-NA). Histopathology 19:29–33
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pich, A., Chiusa, L., Navone, R. et al. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Vichows Archiv A Pathol Anat 424, 143–148 (1994). https://doi.org/10.1007/BF00193493
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00193493